Jarman, M <br/><br/>
Synthesis and cytotoxicity of potential tumor-inhibitory analogues of trimelamol (2,4,6-tris[(hydroxymethyl)methylamino]-1,3,5-triazine) having electron-withdrawing groups in place of methyl.  [electronic resource] 

 -  Journal of medicinal chemistry  Dec 1993 
 - 4195-200 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0022-2623 
<br/><br/><label>Standard No.: </label>10.1021/jm00078a008  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--chemical synthesis<br/>Drug Stability<br/>Half-Life<br/>Humans<br/>Hydrogen-Ion Concentration<br/>Hydrolysis<br/>Leukemia L1210--drug therapy<br/>Lung Neoplasms--drug therapy<br/>Molecular Structure<br/>Plasmacytoma--drug therapy<br/>Rats<br/>Solubility<br/>Structure-Activity Relationship<br/>Triazines--chemistry<br/>Tumor Cells, Cultured